Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients

OBJECTIVE: To examine the efficacy, safety, and tolerability of travoprost 0.004% benzalkonium chloride (BAK)-free compared with previous use of latanoprost 0.005% in Japanese patients living in the US who had primary open-angle glaucoma or ocular hypertension. METHODS: This was an open-label, multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyashiro, Michael J, Lo, Samuel C, Stewart, Jeanette A, Stewart, William C
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999548/
https://www.ncbi.nlm.nih.gov/pubmed/21179218
http://dx.doi.org/10.2147/OPTH.S13460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999548/
https://www.ncbi.nlm.nih.gov/pubmed/21179218
http://dx.doi.org/10.2147/OPTH.S13460

Ejemplares similares